Facebook
Twitter
Telegram
Report an ErrorKiniksa Pharmaceuticals, Ltd. Financial Statements 2011-2024 | KNSA
Annual Financial Statements Kiniksa Pharmaceuticals, Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.43 B | 868 M | 770 M | 1.22 B | 800 M | 904 M | - | - | - | - | - | - | - |
Shares |
70.1 M | 69.4 M | 68.6 M | 61.8 M | 54 M | 49.5 M | - | - | - | - | - | - | - |
Historical Prices |
20.4 | 12.5 | 11.2 | 19.7 | 14.7 | 17.5 | - | - | - | - | - | - | - |
Net Income |
14.1 M | 183 M | -158 M | -161 M | -162 M | -103 M | -64.9 M | -24 M | - | - | - | - | - |
Revenue |
270 M | 220 M | 38.5 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-25.2 M | 9.77 M | -157 M | -157 M | -170 M | -108 M | -65.4 M | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-22.9 M | 12.2 M | -154 M | -155 M | -168 M | -108 M | -65.4 M | -24 M | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 170 M | 108 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
129 M | 98 M | 85.9 M | 45.3 M | 35 M | 21.6 M | 9.04 M | 6.56 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Kiniksa Pharmaceuticals, Ltd.
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
70.6 M | 70.2 M | 69.9 M | 69.8 M | - | 69.4 M | 69.3 M | 69.1 M | - | 68.7 M | 68.4 M | 68.3 M | - | 66 M | 57.9 M | 55.3 M | - | 54.8 M | 54.5 M | 51.8 M | - | 48.2 M | 18.3 M | 2.48 M | - | 1.94 M | 1.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-17.7 M | -13.9 M | 15 M | -12.3 M | - | 224 M | -20 M | -25.2 M | - | -30.5 M | -41.6 M | -49.5 M | - | -43.8 M | -37.5 M | -26.4 M | - | -27.1 M | -37.2 M | -65.8 M | - | -24.4 M | -20.3 M | -16 M | - | -16 M | -11.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
79.9 M | 67 M | 71.5 M | 48.3 M | - | 99.1 M | 27 M | 32.2 M | - | 12.1 M | 7.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
10.6 M | 9.09 M | 7.7 M | 7.04 M | - | 6.94 M | 5.03 M | - | - | 2.77 M | 2.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-16.5 M | -10.9 M | -3.15 M | -11.2 M | - | 46.4 M | -19.4 M | -23.3 M | - | -30.7 M | -40.6 M | -49.3 M | - | -43.2 M | -31.9 M | -29.4 M | - | -30.4 M | -39.3 M | -67.6 M | - | -26.2 M | -21.5 M | -16.3 M | - | -16.2 M | -11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-16.1 M | -10.6 M | -2.86 M | -10.6 M | - | 46.6 M | -19 M | -22.7 M | - | -29 M | -40.1 M | -49 M | - | -41.4 M | -30.7 M | -28.8 M | - | -29.9 M | -38.8 M | -67.2 M | - | -26.1 M | -21.5 M | -16.3 M | - | -16.2 M | -11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | 49.3 M | - | 43.2 M | 31.9 M | 29.4 M | - | 30.4 M | 39.3 M | 67.6 M | - | 26.2 M | 21.5 M | 16.3 M | - | 16.2 M | 11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
38.7 M | 34.5 M | 29.2 M | 29 M | - | 24.7 M | 23.8 M | 22.2 M | - | 20.8 M | 21.8 M | 20.6 M | - | 11.8 M | 9.54 M | 8.49 M | - | 8.43 M | 8.44 M | 8.39 M | - | 5.52 M | 4.33 M | 3.71 M | - | 2.24 M | 2.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency